Podophyllotoxin derivatives: a patent review (2012 – 2014)

Bibliography

• King J. Discovery of podophyllin. Coll J M Sci 1857;2:557-9
   Google Scholar
• Hartwell JL, Schrecker AW. Chemistry of podophyllum. Fortshr Chem Org Naturst 1958;15:83-166
   PubMedGoogle Scholar
• King JL, Sullivan M. The similarity of the effects of podophyllin and colchicines and their use in the treatment of Codylomata acuminate. Science 1946;104:244-5
   Web of Science ®Google Scholar
• Desbene S, Giorgi-Renault S. Drugs that inhibit tubulin polymerization: The particular case of podophyllotoxin and analogues. Curr Med Chem 2002;2:71-90
   Google Scholar
• Chen SW, Wang YH, Jin Y, et al. Synthesis and anti-HIV-1 activities of novel podophyllotoxin derivatives. Bioorg Med Chem Lett 2007;17:2091-5
   PubMed Web of Science ®Google Scholar
• Xu H, Xiao X. Natural products-based insecticidal agents 4. Semisynthesis and insecticidal activity of novel esters of 2-chloropodophyllotoxin against Mythimna separata Walker in vivo. Bioorg Med Chem Lett 2009;19:5415-18
   PubMed Web of Science ®Google Scholar
• Canel C, Moraes RM, Dayan FE, et al. Podophyllotoxin. Phytochemistry 2000;54:115-20
   PubMed Web of Science ®Google Scholar
• Duca M, Guianvarch D, Meresse P, et al. Synthesis and biological study of a new series of 4’-demethyl epipodophyllotoxin derivatives. J Med Chem 2005;48:593-603
   PubMed Web of Science ®Google Scholar
• Kamal A, Hussaini SMA, Malik MS. Recent developments towards podophyllotoxin congeners as potential apoptosis inducers. Anticancer Agents Med Chem 2015;15:565-74
   Google Scholar
• Available from: http://www.rxlist.com/etopophos-drug/warnings-precautions.html
   Google Scholar
• You Y. Podophyllotoxin derivatives: current synthetic approaches for new anticancer agents. Curr Pharm Des 2005;11:1695-717
   PubMed Web of Science ®Google Scholar
• Meresse P, Dechaux E, Monneret C, et al. Etoposide: discovery and medicinal chemistry. Curr Med Chem 2004;11:2443-66
   PubMed Web of Science ®Google Scholar
• Kohrt HE, Patel S, Ho M, et al. Second-line mitoxantrone, etoposide, and cytarabine for acute myeloid leukemia: a single-center experience. Am J Hematol 2010;85:877-81
   PubMed Web of Science ®Google Scholar
• Keating GM. Rituximab: a review of its use in chronic lymphocytic leukaemia, low-grade or follicular lymphoma and diffuse large B-cell lymphoma. Drugs 2010;70:1445-76
   PubMed Web of Science ®Google Scholar
• Felix CA. Leukemias related to treatment with DNA topoisomerase II inhibitors. Med Pediatr Oncol 2001;36:525-53515
   PubMedGoogle Scholar
• Jacob DA, Mercer SL, Osheroff N, et al. Etoposide quinone is a redox-dependent topoisomerase II poison. Biochemistry 2011;50:5660-67
   PubMed Web of Science ®Google Scholar
• Available from: http://research.unc.edu/otd
   Google Scholar
• Lee KH. Novel antitumor agents from higher plants. Med Res Rev 1999;19:569-96
   PubMed Web of Science ®Google Scholar
• Saito H, Yoshikawa H, Nishimura Y, et al. Studies on lignan lactone antitumor agents. II. Synthesis of N-alkylamino- and 2,6-dideoxy-2-aminoglycosidic lignan variants related to podophyllotoxin. Chem Pharm Bull 1986;34:3741-6
   PubMed Web of Science ®Google Scholar
• Pagani O, Zucchetti M, Sessa C, et al. Clinical and pharmacokinetic study of oral NK611, a new podophyllotoxin derivative. Cancer Chemother Pharmacol 1996;38:541-7
   PubMed Web of Science ®Google Scholar
• Utsugi T, Shibata J, Sugimoto Y, et al. Antiumor activity of a novel podophylotoxin derivative (TOP-53) against lung cancer and lung metastatic cancer. Cancer Res 1996;56:2809-14
   PubMed Web of Science ®Google Scholar
• Wilson Byl JA, Cline SD, Utsugi T, et al. DNA topoisomerase II as the target for the anticancer drug TOP-53: mechanistic basis for drug action. Biochemistry 2001;4V0:712-18
   Google Scholar
• Barret JM, Etievant C, Baudouin C, et al. F11782, a novel catalytic inhibitor of topoisomerases I and II, induces a typical, yet cytotoxic DNA double-strand breaks in CHO-K1 cells. Anticancer Res 2002;22:187-92
   PubMed Web of Science ®Google Scholar
• Barret JM, Kruczynski A, Chantal Etiévant C, et al. Synergistic effects of F 11782, a novel dual inhibitor of topoisomerases I and II, in combination with other anticancer agents. Cancer Chemother Pharmacol 2002;49:479-86
   PubMed Web of Science ®Google Scholar
• Kluza J, Mazinghien R, Irwin H, et al. Relationships between DNA strand breakage and apoptotic progression upon treatment of HL-60 leukemia cells with tafluposide or etoposide. Anticancer drugs 2006;17:155-64
   PubMed Web of Science ®Google Scholar
• Chen MC, Pan SL, Shi Q, et al. QS-ZYX-1-61 induces apoptosis through topoisomerase II in human non-small-cell lung cancer A549 cells. Cancer Sci 2012;103:80-7
   PubMed Web of Science ®Google Scholar
• Kruczynski A, Pillon A, Créancier L, et al. F14512, a polyamine-vectorized anti-cancer drug, currently in clinical trials exhibits a marked preclinical anti-leukemic activity. Leukemia 2013;27:2139-48
   PubMed Web of Science ®Google Scholar
• Available from: http://sunshinebiopharma.com/
   Google Scholar
• Li J, Sun H, Jin L, et al. Alleviation of podophyllotoxin toxicity using coexisting flavonoids from Dysosma versipellis. PLoS One 2013;8:72099
   Google Scholar
• Bohlin L, Rosen B. Podophyllotoxin derivatives: Drug discovery and development. Drug Discov Today 1996;1:343-51
   Web of Science ®Google Scholar
• Damayanthi Y, Lown JW. Podophyllotoxins: current status and recent developments. Curr Med Chem 1998;5:205-52
   PubMed Web of Science ®Google Scholar
• Qian Liu Y, Tian J, Qian K, et al. Recent progress on C-4-modified podophyllotoxin analogs as potent antitumor agents. Med Res Rev 2015;35:1-62
   PubMed Web of Science ®Google Scholar
• Zihua J, Chengting Z, Miao HJ, et al. Biotin-podophyllotoxin esterified derivatives and pharmaceutical compositions and methods for their preparation and application. CN104098594A; 2014
   Google Scholar
• Jie TY, Lu C, Wei Z. Esterified podophyllum derivative with antineoplastic activity and preparation method and application thereof. CN103351395A;2013
   Google Scholar
• Jie TY, Li X. Esterified podophyllum derivative with antitumor activity and preparation method and usage of esterified podophyllum derivative. CN102875565A;2013
   Google Scholar
• Valeur E, Bradley M. Amide bond formation: beyond the myth of coupling reagents. Chem Soc Rev 2009;38:606-31
   PubMed Web of Science ®Google Scholar
• Hua XX, Jie SW, Qi Y, et al. Derivative of dysosma versipellis, and composition, preparation method and use thereof. CN102850364A;2013
   Google Scholar
• Hua XX, Hai LQ, Qi Y, et al. Podophyllotoxin derivative as well as salt, preparation method and application thereof. CN103539801A;2014
   Google Scholar
• Kamal A, Suresh P, Ashwini KB, et al. Substituted 4β-acrylamidopodophyllotoxin congeners as antitumour antibiotics and the process for preparation thereof. WO2012063250A1;2012
   Google Scholar
• Kamal A, Suresh P, Ashwini KB, et al. Substituted 4β-acrylamidopodophyllotoxin congeners as antitumour antibiotics and the process for preparation thereof. US20130225672A1;2013
   Google Scholar
• Jie TY, Lu C, Wei Z. Acidamide substitution podophyllum derivative with antineoplastic activity and preparation method and application thereof. CN103351394A;2013
   Google Scholar
• Leoni A, Locatelli A, Morigi R, et al. Novel thiazole derivatives: a patent review (2008 -- 2012; Part 1). Expert Opin Ther Patent 2014;24:201-16
   PubMed Web of Science ®Google Scholar
• Kamal A, Syed MAH, Mohammed SM. Therapeutic potential of benzothiazoles: a patent review (2010 - 2014). Expert Opin Ther Patent 2015;25:335-49
   PubMed Web of Science ®Google Scholar
• Mei ZZ, Hua CW, Hong C. 4β-nitrogen-substituted furan tertiary amine podophyllotoxin derivative as well as preparation method and application thereof. CN103804388A;2014
   Google Scholar
• Kun H, Lin W, Ren J, et al. 4-amino oxadiazole epipodophyllotoxin derivative and preparation method and application thereof. CN102432622A;2012
   Google Scholar
• Zihua J, Ting ZC, Miao HJ, et al. Podophyllotoxin glycoside and acylated glycoside, and medicinal composition, preparationand application thereof. CN103570780A;2014
   Google Scholar
• Jie TY, Bai J. Sulfur-substituted podophyllum derivative and bioconversion, separation and purification method thereof. CN102757443A; 2012
   Google Scholar
• Jie TY, Bai J. Sulfur-substituted podophyllum derivative and synthetic method and application thereof. CN102757442A; 2012
   Google Scholar
• Jie TY, Long LJ, Wei Z, et al. Sulfur-substituted podophyllotoxin derivative as well as synthetic method and application thereof. CN103613601A;2014
   Google Scholar
• Jie TY, Huai W, Wei Z, et al. Nitrogen-substituted podophyllotoxin derivative with anti-tumor activity and preparation method and use thereof. CN103601732A;2014
   Google Scholar
• Jie TY, Li X. Nitrogen substitution podophyllum type derivatives with antitumor activity and preparation method and application thereof. CN102875564A;2013
   Google Scholar
• Lee KH, Beers SA, Mori M, et al. Antitumor Agents.111. New 4-hydroxylated and 4-halogenated anilino derivatives of 4’-demethylepipodophyllotoxin as potent inhibitors of human DNA topoisomerase II. J Med Chem 1990;33:1364-8
   PubMed Web of Science ®Google Scholar
• Slilaty SN. Gem-difluorinated c-glycoside compounds as anti-cancer agents. WO2014107803A1;2014
   Google Scholar
• Jie TY, Yong Y, Wei Z, et al. Anilino podophyllotoxin derivative with anti-tumor activity and preparation method and application thereof. CN103613600A;2014
   Google Scholar
• Wei LD, Zhang X, Luo Y, et al. Etoposide compound with hydroxamic acid structure and preparation method and usage thereof. CN102603761A;2012
   Google Scholar
• Passerella D, Peretto B, Yepes RBY, et al. Synthesis and biological evaluation of novel thiocolchicine-podophyllotoxin conjugates. Eur J Med Chem 2010;45:219-26
   PubMed Web of Science ®Google Scholar
• Kamal A, Kumar BA, Suresh P, et al. An efficient one-pot synthesis of benzothiazolo-4β-anilino-podophyllotoxin congeners: DNA topoisomerase-II inhibition and anticancer activity. Bioorg Med Chem Lett 2011;21:350-3
   PubMed Web of Science ®Google Scholar
• Srivastava S, Martin A, Athavale M, et al. Agents for eliminating tumour-initiating cells. WO2014097318A2;2014
   Google Scholar
• Kamal A, Suresh P, Kumar BA, et al. 4-aza-2, 3-didehydropodophyllotoxin compounds and process for the preparation thereof. WO2012076942A1;2012
   Google Scholar
• Kamal A, Suresh P, Kumar BA, et al. 4-aza-2, 3-didehydropodophyllotoxin compounds and process for the preparation thereof. US20130245048A1;2013
   Google Scholar
• Yun G, Yi W, Ying MC, et al. Anticancer 4’-nor-anthricin and preparation method thereof. CN103304574A;2013
   Google Scholar
• Hong LZ, Hua MX, Yun G, et al. Anti-cancer 4’-demethylation-4’-oxy-cyclobutyl formyl-deoxidation podophyllotoxin and preparation method thereof. CN103214495A;2013
   Google Scholar